semaglutide removed from shortage list fda resolved feb 21 2025 Novo's Wegovy and Ozempic US list, compounders on notice FDA Declares Shortage of Novo – GLP-1 Weight-Loss Drugs Off Shortage

In one study, patients regained about two-thirds of the weight they had lost just one year after stopping semaglutide treatment, and their cardiometabolic risk markers (blood sugar, cholesterol, etc.) reverted toward baseline (source)

A More Affordable Solution Theres a more affordable and effective way to manage weight

Pricing ranges from $25 to $75 per injection depending on provider type, geographic location, and whether the service is bundled into a larger program

You might take berberine with main meals (to reduce gastrointestinal effects and support its glucose-modulating actions) and L-carnitine either with meals or separately, depending on your routine and tolerance

D-Ribose D-Ribose is an organic compound produced by the body